Immunocore
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $80,248 | $75,400 | $70,502 | $105,635 |
Gross Profit | 79,800 | 73,693 | 70,256 | 105,882 |
EBITDA | -8,502 | -16,017 | -20,191 | -18,737 |
EBIT | -9,537 | -17,009 | -21,202 | -18,858 |
Net Income | 8,736 | -11,616 | -24,436 | -26,417 |
Net Change In Cash | 80,248 | 75,400 | 70,502 | 105,635 |
Free Cash Flow | 20,299 | 23,141 | -5,017 | -11,439 |
Cash | 537,767 | 504,985 | 832,821 | 442,626 |
Basic Shares | 52,808 | 50,014 | 49,877 | 48,888 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $249,428 | $143,737 | $26,520 | $30,114 |
Gross Profit | 248,391 | 143,283 | -46,706 | -44,695 |
EBITDA | -51,646 | -38,354 | -166,715 | -102,586 |
EBIT | -55,736 | -43,689 | -174,306 | -111,562 |
Net Income | -55,287 | -41,224 | -131,523 | -74,093 |
Net Change In Cash | 249,428 | 143,737 | 26,520 | 30,114 |
Free Cash Flow | -2,485 | -33,466 | -130,757 | -63,648 |
Cash | 442,626 | 332,539 | 237,886 | 129,716 |
Basic Shares | 48,888 | 45,714 | 43,862 | 31,782 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.49 |
2024-09-30 | $0.17 |
2024-06-30 | -$0.23 |
2024-03-31 | -$0.49 |
